Latest Episodes
57
Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation
Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host...
56
Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael...
55
Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®
How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks...
54
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...
53
Episode 53: Frank David, Founder and Managing Director, Pharmagellan
How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan...
52
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...